Feb 12, 2018 13:15 pm UTC| Business
NEW YORK, Feb. 12, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Haemonetics...
Rick Van Kirk, CEO of Pro-Dex, Inc. Returns to “Stock Day” with Everett Jolly
Feb 12, 2018 13:12 pm UTC| Business
PHOENIX, Feb. 12, 2018 -- Pro-Dex, Inc. (NASDAQ:PDEX) (“Pro-Dex” the “Company”), CEO Rick Van Kirk joined Everett Jolly on “Stock Day” to review recent accomplishments and 2018 expectations. Pro-Dex is a medical...
Feb 12, 2018 13:10 pm UTC| Business
NEW YORK, Feb. 12, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Green Dot...
SanSal Wellness Holdings Inc. Issues CEO Letter to Shareholders and Starts Trading on OTCQB
Feb 12, 2018 13:06 pm UTC| Business
FORT LAUDERDALE, FL, Feb. 12, 2018 -- SanSal Wellness Holdings, Inc. (“SanSal Wellness” or the “Company”) (OTCQB: SSWH), a vertically-integrated agribusiness focused on producing full spectrum natural...
Delek US Announces a Definitive Agreement to Sell West Coast Asphalt Terminals
Feb 12, 2018 13:05 pm UTC| Business
BRENTWOOD, Tenn., Feb. 12, 2018 -- Delek US Holdings, Inc. (NYSE:DK)(“Delek”) announced today that it has reached a definitive agreement to sell four asphalt terminals to an affiliate of Andeavor. This transaction...
Feb 12, 2018 13:05 pm UTC| Business
TUSTIN, Calif. and BOSTON, Feb. 12, 2018 -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) (“Avid”) and Oncologie, Inc. today announced that the companies have entered into an Asset Assignment and Purchase...
Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse®
Feb 12, 2018 13:03 pm UTC| Business
Positive meeting with the FDA about the resubmission of an NDA for FirdapseResubmission of NDA for Firdapse on schedule for end of the first quarter CORAL GABLES, Fla., Feb. 12, 2018 -- Catalyst Pharmaceuticals, Inc....